« Back to Record
Citation APA

Thémans, P., Belkhir, L., Dauby, N., Yombi, J.-C., De Greef, J., Delongie, K. A., Vandeputte, M., Nasreddine, R., Wittebole, X., Wuillaume, F., Lescrainier, C., Verlinden, V., Kiridis, S., Dogné, J.-M., Hamdani, J., Wallemacq, P., & Musuamba, F. T. S. F. (2020). Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization. European journal of drug metabolism and pharmacokinetics, 45(6), 703-713. doi:10.1007/s13318-020-00648-y


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/313092

Thémans, P., Belkhir, L., Dauby, N., Yombi, J.-C., De Greef, J., Delongie, K. A., Vandeputte, M., Nasreddine, R., Wittebole, X., Wuillaume, F., Lescrainier, C., Verlinden, V., Kiridis, S., Dogné, J.-M., Hamdani, J., Wallemacq, P., & Musuamba, F. T. S. F. (2020). Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization. European journal of drug metabolism and pharmacokinetics, 45(6), 703-713. doi:10.1007/s13318-020-00648-y